XL999 Terminated Phase 2 Trials for Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00322673Study of XL999 in Patients With Acute Myeloid Leukemia (AML)